In contrast, patients with strong tumor HER2 expression had significantly elevated serum LH levels (22.1 mIU/ml) compared to those in patients without tumor HER2 expression (18.3 mIU/ml, P = .011). This evidence concerns the gene ERBB2 and neoplasm.